FLT3 and acute myeloid leukemia: Another study showed that the FLT3 inhibitor quizartinib upregulates inflammatory genes in AML cells, and combined with anti-inflammatory glucocorticoids enhanced cell death in FLT3 mutants, but not wild-type [58].